Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.1101/2020.11.30.403634

License

CC-BY

Other Formats

PDF